World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00074906
Date of registration: 23/12/2003
Primary sponsor: Takeda Global Research & Development Center, Inc.
Public title: Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)
Scientific title: Venticute in Patients With Pneumonia or Aspiration of Gastric Contents Leading to Intubation, Ventilation, and Severe Oxygenation Impairment: A Randomized, Multinational, Multicenter, Parallel Group, Double Blind, Control Group Study
Date of first enrolment: November 2003
Target sample size: 1200
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00074906
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment  
Countries of recruitment
Argentina Australia Austria Belgium Brazil Canada Chile Czech Republic
Denmark Estonia Finland France Germany Greece Hungary Israel
Netherlands New Zealand Poland Russian Federation Slovakia South Africa Spain Sweden
Switzerland United Kingdom United States
Contacts
Name:   Werner Seeger, MD
Address: 
Telephone:
Email:
Affiliation:  Justus-Liebig-Universität, Gießen, Germany
Name:   Roger G. Spragg, MD
Address: 
Telephone:
Email:
Affiliation:  University of California and La Jolla Veterans Affairs Medical Center, San Diego, CA, USA
Name:   Andreas Günther, MD
Address: 
Telephone:
Email:
Affiliation:  University of Giessen
Key inclusion & exclusion criteria

Main inclusion criteria:

- Patient has been intubated due to one of the following primary pulmonary insults:
aspiration of gastric contents or pneumonia

Main exclusion criteria:

- Principal source of infection or sepsis is outside the lung

- Severe pre-existing lung disease

- Cancer metastatic to the lung or any end stage malignancy

- History of lung, liver, pancreas, small bowel, or bone marrow/stem cell
transplantation

- Patient is morbidly obese

- Patient has a diagnosis of acute necrotizing pancreatitis

Additional criteria may apply and examination by an investigator is required to determine
eligibility.



Age minimum: 12 Years
Age maximum: 85 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Pneumonia
Intervention(s)
Drug: Venticute
Primary Outcome(s)
Survival on day 28 [Time Frame: 28 days]
Secondary Outcome(s)
How long the lung and the patient (overall) are recovering [Time Frame: 28 days]
Secondary ID(s)
BY2001/M1-007
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history